CTVA
Status-Quo-PlayerCorteva
$83.51
-0.41%
as of 13 Apr
Power Core
Corteva's moat is the irreplicable integration of proprietary germplasm, embedded trait technologies, and multi-decade regulatory clearances that create compounding biological lock-in at the farm level.
Direction of Movement
Upward, With Separation Execution as the Key Variable
ROC 200
+15.2%
CTVA
Corteva
$83.51
-0.41%
as of 13 Apr
DCF Fair Value: $67.55
Market data unavailable
Company Profile
Corteva Inc. is a global pure-play agriculture company providing seed, crop protection, and digital solutions to support farmer productivity and address agricultural challenges worldwide. The Seed segment develops and supplies advanced germplasm and trait technologies that enhance crop yield, disease and pest resistance, and herbicide tolerance, while also offering digital tools to optimize farm management and profitability. The Crop Protection segment delivers herbicides, fungicides, biologicals, and other technologies to manage weeds, insects, diseases, and pests, with recent emphasis on nature-inspired solutions and emerging categories. Corteva serves farmers and stakeholders throughout the global food supply chain with a diverse portfolio of recognized agricultural brands. The company maintains a strong focus on innovation across seed genetics, crop protection chemistry, and digital agriculture, supported by substantial research and development investment. Corteva announced plans to separate into two independent, publicly traded companies through a tax-free spin-off expected in the second half of 2026, creating dedicated entities focused on seed and crop protection respectively.